8-K: Centrus Launches $1 Billion At-the-Market Equity Offering

Centrus Energy Corp. announced a new at-the-market equity offering program to sell up to $1 billion in Class A common stock for general corporate purposes.

Summary

• Centrus Energy Corp. (LEU) has entered into a Sales Agreement for an at-the-market (ATM) equity offering program.
• The company may offer and sell, from time to time at its sole discretion, shares of its Class A common stock with an aggregate offering price of up to $1,000,000,000.
• Sales will be conducted through a syndicate of ten sales agents, including Barclays Capital Inc., Citigroup Global Markets Inc., and UBS Securities LLC.
• Shares will be sold at market prices, prices related to prevailing market prices, or negotiated prices, primarily through NYSE American LLC or other trading markets.
• Centrus is not obligated to sell any shares under the program.
• The company will pay the sales agents a commission equal to 1.50% of the gross sales proceeds of any shares sold.
• Proceeds are expected to be used for general working capital and corporate purposes, which may include investment in technology development, debt repayment or repurchase, capital expenditures, and potential acquisitions.
• The Sales Agreement will terminate upon the earlier of the sale of all shares or termination in accordance with its terms.
• The offering is made pursuant to the company's Registration Statement on Form S-3 (File No. 333-291305) and a prospectus supplement, both filed on November 6, 2025.
• A previous At Market Issuance Sales Agreement, dated February 9, 2024, has been terminated.

Sentiment

Score: 7

Explanation: The establishment of a significant ATM equity offering provides Centrus with substantial financial flexibility to pursue strategic growth initiatives and manage its capital structure, which is generally positive for long-term stability and growth. However, it also introduces potential shareholder dilution.

Positives

• Provides Centrus with significant financial flexibility and access to capital of up to $1 billion.
• Diversifies funding sources for general corporate purposes, including strategic investments in technology development and potential acquisitions.
• The at-the-market structure allows the company to control the timing and pricing of share sales, potentially minimizing market impact compared to a large, fixed-price offering.

Negatives

• Potential for dilution of existing shareholders as new shares are issued under the program.
• The offering could exert downward pressure on the stock price if a substantial number of shares are sold over time.
• A commission of 1.50% on gross sales proceeds will reduce the net capital raised by the company.

Risks

• Market demand and competition may impact the company's ability to sell shares at favorable prices.
• Changes in economic or industry conditions could adversely affect the company's business and the offering.
• Geopolitical conflicts, including the war in Ukraine, pose ongoing risks.
• Supply chain disruptions could impact operations.
• The imposition of tariffs and/or sanctions may affect the company's ability to obtain, deliver, transport, or sell LEU or SWU components.
• Regulatory approvals and compliance requirements are subject to change.
• Technological changes could impact the company's competitive position.
• DOE procurement decisions and U.S. government appropriations are critical to certain business segments.
• Government decisions regarding the company's lease with the DOE in Piketon, Ohio, including term and scope of permitted activities, present uncertainty.
• The ability to attract qualified employees for potential expansion in Oak Ridge, Tennessee, or Piketon, Ohio, is crucial.
• The company's ability to execute its strategic initiatives may be affected by various factors.
• Other risks are discussed in the company's Annual Report on Form 10-K for the year ended December 31, 2024, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.

Future Outlook

Centrus expects to use any proceeds from the ATM program for general working capital and corporate purposes, including investment in technology development or deployment, repayment or repurchase of outstanding debt, capital expenditures, and potential acquisitions. The company is pioneering production of High-Assay, Low-Enriched Uranium (HALEU) and leading efforts to restore America's uranium enrichment capabilities at scale to meet clean energy, energy security, and national security needs.

Management Comments

• Centrus is a trusted supplier of nuclear fuel components for the nuclear power industry.
• Centrus provides value to its utility customers through the reliability and diversity of its supply sources – helping them meet the growing need for clean, affordable, carbon-free electricity.
• With world-class technical and engineering capabilities, Centrus is pioneering production of High-Assay, Low-Enriched Uranium and is leading the effort to restore America's uranium enrichment capabilities at scale to meet America's clean energy, energy security, and national security needs.

Industry Context

The nuclear power industry is experiencing a growing demand for clean, carbon-free electricity. Centrus's strategic focus on High-Assay, Low-Enriched Uranium (HALEU) production and the restoration of U.S. uranium enrichment capabilities aligns with national energy security objectives and global clean energy trends, especially in light of geopolitical developments and acts like the Prohibiting Russian Uranium Imports Act. This ATM offering provides crucial capital to support these strategic initiatives and maintain competitiveness in a vital sector.

Related Party Transactions

• No relationship, direct or indirect, exists between or among the Company or its subsidiaries or any affiliate of any of them, on the one hand, and the directors, officers and stockholders of the Company or its subsidiaries, on the other hand, that is required by the Securities Act to be described in the Registration Statement and the Prospectus that is not so described.
• The Company does not have any material lending or other relationship with any bank or lending affiliate of any Agent and does not intend to use any of the proceeds from the sale of the Stock to repay any outstanding debt owed to any affiliate of any Agent.

Stakeholder Impact

• Shareholders: Potential for dilution due to new share issuance; potential for long-term value creation if capital is effectively deployed for strategic growth.
• Creditors: Potential for debt repayment or repurchase, which could improve the company's credit profile.
• Employees: Potential for growth and stability if investments in technology and expansion create new opportunities.
• Customers: Enhanced reliability and diversity of supply sources for nuclear fuel components, supporting the growing need for clean energy.

Next Steps

• Centrus may, from time to time, offer and sell shares under the ATM program at its sole discretion.
• The company will set parameters for sales, including the number of shares, anticipated sale dates, daily limits, and minimum prices.
• The company will disclose the number of shares sold, net proceeds, and compensation paid in its Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q.

Key Dates

Recommendation

The ATM offering provides Centrus with significant financial flexibility to fund strategic initiatives in a growing industry (nuclear fuel, HALEU). This is a positive for long-term growth prospects. However, the potential for substantial shareholder dilution from a $1 billion offering, coupled with the inherent risks of the nuclear industry and geopolitical factors, suggests a 'hold' position. Investors should monitor the actual pace and pricing of share sales and the effectiveness of capital deployment.

Keywords

Centrus Energy, LEU, ATM offering, equity offering, common stock, capital raise, nuclear fuel, uranium enrichment, Form S-3, SEC filing, dilution, working capital, debt repayment, acquisitions, HALEU